Tilaknagar Industries Ltd. announces Q4 & FY 26 Results - achieves record volume of 8mn cases in Q4 FY26 and 20mn cases in FY26
TI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tilaknagar Industries achieved record volumes with 8 million cases sold in Q4 FY26 (134.7% YoY growth) and ~20 million cases in FY26 (67.6% YoY growth). Q4 revenue jumped 147.5% to Rs. 949 crore, with FY26 revenue at Rs. 2,346 crore (69.9% growth). EBITDA grew 97.1% to Rs. 155 crore in Q4 and 64.5% to Rs. 419 crore for FY26. PAT excluding exceptional items rose 6.5% to Rs. 82 crore in Q4 and 30.3% to Rs. 299 crore for FY26. The board recommended dividend of Re. 1 per share. The strong growth includes the first full quarter of Imperial Blue operations under TI ownership, with integration progressing well.
The company delivered exceptional volume and revenue growth driven by the Imperial Blue acquisition. Shareholders can expect positive sentiment given strong profitability, record volumes, and dividend recommendation. The management targets EBITDA margin of 16-18% and Net Debt/EBITDA below 1.0x.